Drug General Information
Drug ID	D05LKZ
Former ID	DIB012486
Drug Name	HPP-607
Indication	Cancer [ICD9: 140-229; ICD10:C00-C96]		Phase 1	[522723]
Company	TransTech Pharma Inc
Structure		Download 2D MOL 3D MOL
Target and Pathway
Target(s)	Aurora protein kinase	Target Info	Inhibitor	[543524]
KEGG Pathway	Oocyte meiosis
Reactome	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
	Separation of Sister Chromatids
	Resolution of Sister Chromatid Cohesion
	RHO GTPases Activate Formins
WikiPathways	EGF/EGFR Signaling Pathway
	JAK/STAT
	Gastric Cancer Network 1
	Integrated Breast Cancer Pathway
	APC/C-mediated degradation of cell cycle proteins
References
Ref 522723	ClinicalTrials.gov (NCT00939172) TTP607 in Refractory Solid Malignancies. U.S. National Institutes of Health.
Ref 543524	(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1936).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.